Latest Biotech News

LB Pharmaceuticals successfully raised $285 million in its initial public offering on Nasdaq, marking the largest biotech IPO in over six months. The company plans to advance LB-102, an oral...

Researchers at Harvard Medical School developed PDGrapher, an artificial intelligence model that predicts treatments capable of reversing disease states in cells by identifying gene targets to...

Groundbreaking studies reveal that small cell lung cancer (SCLC) cells integrate into neural circuits by forming active synaptic connections with neurons both within primary lung tumors and brain...

Sophont AI secured $9.2 million in funding to develop foundational AI models capable of analyzing diverse specialized medical data types. The company aims to create open-source, multimodal AI...

Lucid Diagnostics closed a public offering that raised $26.9 million, increasing its cash runway to support commercialization efforts for its EsoGuard test, a DNA methylation assay designed to...

Jackson Laboratory scientists developed a cocktail of non-neutralizing antibodies targeting influenza A virus (IAV) that demonstrated protection across nearly all tested flu strains, including...

The University of Minnesota Medical School secured a $3.3 million NIH grant to conduct a comprehensive, five-year longitudinal study focused on infants born with congenital cytomegalovirus (cCMV)...

Novartis has agreed to acquire clinical-stage biotech Tourmaline Bio for approximately $1.4 billion, obtaining rights to the anti-IL-6 monoclonal antibody pacibekitug aimed at treating...

Johnson & Johnson received U.S. Food and Drug Administration approval for Inlexzo, a drug-device combination that delivers gemcitabine intravesically to treat Bacillus Calmette-Guérin unresponsive...

LB Pharmaceuticals raised $285 million from its initial public offering on Nasdaq, marking the largest biotech public offering in over six months. The company plans to advance LB-102, an oral...

Capsida Biotherapeutics' clinical trial testing a gene therapy for STXBP1 encephalopathy, a rare pediatric neurological disorder, suffered a significant setback after a patient died shortly...

Eli Lilly introduced TuneLab, a collaborative platform offering biotech companies free access to its sophisticated artificial intelligence models developed over two decades to predict small...

Scientists at Jackson Laboratory developed a novel antibody therapy that provides broad protection against diverse influenza A virus strains, including those with pandemic potential, by targeting...

Merck announced it is discontinuing all research operations in the United Kingdom and scrapping plans for a £1 billion London drug research center. The decision reflects frustration over lack of...

Multiple groundbreaking studies have revealed that small cell lung cancer (SCLC) cells form functional synapses with neurons, integrating into neural circuits to promote tumor growth. This...

A landmark study by the Salk Institute and collaborators illuminated the critical role of the gut microbiome’s composition and function in pediatric undernutrition and growth stunting. Analysis of...

Belgian bioinformatics company Aspect Analytics closed a €10 million Series A round to enhance and extend its cloud-based Weave platform, which integrates and analyzes multiomics spatial biology...

Novartis announced the acquisition of Tourmaline Bio for $1.4 billion, acquiring the anti-IL-6 monoclonal antibody pacibekitug targeting atherosclerotic cardiovascular disease (ASCVD)....

The FDA approved Johnson & Johnson's drug-device combination, Inlexzo (formerly TAR-200), for treating Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer with...

LB Pharmaceuticals raised $285 million in a Nasdaq IPO, the largest biotech offering in over half a year, exceeding initial projections. The company is developing LB-102, an oral derivative of...